DK69091D0 - Langkaedede alkoholer til in vivo behandling af nervecellelidelser og farmaceutiske praeparater indeholdende saadanne alkoholer - Google Patents

Langkaedede alkoholer til in vivo behandling af nervecellelidelser og farmaceutiske praeparater indeholdende saadanne alkoholer

Info

Publication number
DK69091D0
DK69091D0 DK91690A DK69091A DK69091D0 DK 69091 D0 DK69091 D0 DK 69091D0 DK 91690 A DK91690 A DK 91690A DK 69091 A DK69091 A DK 69091A DK 69091 D0 DK69091 D0 DK 69091D0
Authority
DK
Denmark
Prior art keywords
alcohols
nervo
long
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK91690A
Other languages
English (en)
Other versions
DK69091A (da
Inventor
Jacques Borg
Carl W Cotman
Patrick J Kesslak
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK69091D0 publication Critical patent/DK69091D0/da
Publication of DK69091A publication Critical patent/DK69091A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK069091A 1988-10-18 1991-04-17 Langkaedede alkoholer til in vivo behandling af nervecellelidelser og farmaceutiske praeparater indeholdende saadanne alkoholer DK69091A (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US25992888A 1988-10-18 1988-10-18
US25991888A 1988-10-18 1988-10-18
US25991988A 1988-10-18 1988-10-18
US25996488A 1988-10-18 1988-10-18
US26930088A 1988-11-09 1988-11-09
PCT/US1989/004630 WO1990004388A1 (en) 1988-10-18 1989-10-16 In vivo neurotrophic cytoprotective alcohols

Publications (2)

Publication Number Publication Date
DK69091D0 true DK69091D0 (da) 1991-04-17
DK69091A DK69091A (da) 1991-06-14

Family

ID=27540413

Family Applications (1)

Application Number Title Priority Date Filing Date
DK069091A DK69091A (da) 1988-10-18 1991-04-17 Langkaedede alkoholer til in vivo behandling af nervecellelidelser og farmaceutiske praeparater indeholdende saadanne alkoholer

Country Status (8)

Country Link
US (1) US5135956A (da)
EP (1) EP0439544B1 (da)
JP (1) JPH04505003A (da)
AU (1) AU633526B2 (da)
CA (1) CA2000940A1 (da)
DE (1) DE68913756T2 (da)
DK (1) DK69091A (da)
WO (1) WO1990004388A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166317A (en) * 1988-10-31 1992-11-24 Houston Biotechnology Incorporated Neurotrophic factor
US5070107A (en) * 1989-04-28 1991-12-03 Lidak Pharmaceuticals Systemic antiviral treatment
US5071879A (en) * 1989-04-28 1991-12-10 Lidak Pharmaceuticals Systemic antiviral treatment
EP0448697B1 (fr) * 1989-10-13 1996-04-10 Neurofit Analogues de la vitamine a, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
US5444042A (en) * 1990-12-28 1995-08-22 Cortex Pharmaceuticals Method of treatment of neurodegeneration with calpain inhibitors
US6174862B1 (en) * 1991-04-22 2001-01-16 Ramot University Authority For Applied Research And Industrial Development, Ltd. Neurotrophic peptides of activity dependent neurotrophic factor
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
AU6836394A (en) * 1993-06-01 1994-12-20 Cortex Pharmaceuticals, Inc. Use of metabotropic receptor agonists in progressive neurodegenerative deseases
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5906976A (en) * 1996-10-22 1999-05-25 Ramot-University Authority For Applied Research And Industrial Development, Ltd. Method and composition for treating neuronal degeneration
US6962930B1 (en) 1997-06-06 2005-11-08 Lohocla Research Corporation Compounds, compositions and method suitable for amelioration of withdrawal syndromes and withdrawal-induced brain damage
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
US6506378B1 (en) 1998-12-16 2003-01-14 Arch Development Corporation Vesicular monoamine transporter gene therapy in Parkinson's disease
US6265147B1 (en) * 1999-12-01 2001-07-24 The Board Of Trustees Of The Leland Stanford Junior University Method of screening for neuroprotective agents
BR0213323A (pt) * 2001-10-16 2005-01-25 Avanir Pharmaceuticals Inibição viral por n-docosanol
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US8202541B2 (en) * 2006-02-07 2012-06-19 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
EP2274016B1 (en) * 2008-04-03 2012-07-25 F. Hoffmann-La Roche AG Pegylated igf-i variants for use in the treatment of neuromuscular disorders
US8946301B2 (en) 2011-11-29 2015-02-03 Als Therapy Development Institute Targeting of T-lymphocytes to treat amyotrophic lateral sclerosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031376A (en) * 1956-10-11 1962-04-24 Levin Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same
US4186212A (en) * 1978-03-09 1980-01-29 Howell F Maurice Animal feed containing high molecular weight aliphatic alcohols
US5055613A (en) * 1988-02-18 1991-10-08 G. D. Searle & Co. Metabolites of pentanedioic acid derivatives
US4874794A (en) * 1989-04-28 1989-10-17 Lidak Biopharmaceuticals Inflammatory disease treatment

Also Published As

Publication number Publication date
JPH04505003A (ja) 1992-09-03
EP0439544B1 (en) 1994-03-09
CA2000940A1 (en) 1990-04-18
US5135956A (en) 1992-08-04
EP0439544A1 (en) 1991-08-07
WO1990004388A1 (en) 1990-05-03
DK69091A (da) 1991-06-14
DE68913756T2 (de) 1994-08-11
AU633526B2 (en) 1993-02-04
AU4510889A (en) 1990-05-14
DE68913756D1 (de) 1994-04-14

Similar Documents

Publication Publication Date Title
DK69091D0 (da) Langkaedede alkoholer til in vivo behandling af nervecellelidelser og farmaceutiske praeparater indeholdende saadanne alkoholer
DK623087A (da) Laegemiddelpraeparat og catecholderivater til brug ved fremstilling deraf
DK330287A (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK273689D0 (da) 4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
NO862095L (no) Farmasoeytiske preparater inneholdende vevsplasmnogenaktivitator og fremgangsmaate for deres fremstilling.
DK413588A (da) Vaevsfaktor-inhibitor (tfi) og fremgangmsaade til fresmtilling heraf
DK272486D0 (da) Tienopyridoner og farmaceutiske praeparater indeholdende dem
DK287188D0 (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK415388D0 (da) Farmaceutiske praeparater indeholdende pyrimidinderivater og fremgangsmaade til fremstilling deraf
DK650089D0 (da) Furanalkylketoner og farmaceutiske praeparater deraf
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK397788D0 (da) Polyarylalkan-oligomer-praeparater og fremgangsmaade til fremstilling deraf
DK207289D0 (da) Lotionshampoo med antiskaelvirkning og fremgangsmaade til fremstilling heraf
DK225788A (da) Poroes harpiksfilm og fremmgangsmaade til fremstilling deraf
DK590987D0 (da) Peptid og farmaceutisk praeparat indeholdende et saadant peptid
DK597784D0 (da) Silanmodificerede esterblandinger, fremgangsmaader til deres fremstilling samt deres anvendelse i farmaceutiske og kosmetiske praeparater
DK369088A (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK488688A (da) Azolidindion-derivater og farmaceutiske praeparater indeholdende disse
DK670588A (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
DK547288A (da) 5-substituerede-3-phenyl-3-(1h-imidazol-1-ylmethyl)-2-methylisoxazolidiner og farmaceutiske praeparater indeholdende disse
DK304789D0 (da) Saccharid og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende saccharidet
DK280388D0 (da) Fremgangsmaade til stabilisering af biologiske og farmaceutiske produkter
DK560189A (da) Insekticidpraeparater i forpakning og fremgangsmaade til insekticidbehandling dermed